List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 972 studies with search of: kidney transplantation
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
Conditions: End-Stage Renal Disease;   Kidney Failure
Interventions: Biological: CD4+CD25+CD127lowFoxP3+ T regulatory cells injection;   Drug: Alemtuzumab;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Everolimus;   Procedure: Kidney transplantation
2 Active, not recruiting Studies of Kidney Transplant Outcome
Conditions: Transplant Recipient (Kidney);   Steroid-Free Maintenance Immunosuppression;   Post-Transplant Infections;   Thymoglobulin
Interventions: Drug: Steroid-Free Maintenance Immunosuppression;   Other: Infection After Kidney Transplantation;   Drug: Evaluation of the DGF nomogram in Thymoglobulin
3 Active, not recruiting Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
Conditions: End-Stage Renal Disease;   Renal Transplantation
Interventions: Drug: rabbit anti-thymocyte globulin (rATG);   Drug: mycophenolate mofetil;   Drug: rabbit anti-thymocyte globulin;   Procedure: kidney transplantation;   Drug: sirolimus;   Drug: tacrolimus
4 Recruiting Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
Conditions: End-stage Renal Failure;   Graft Rejection
Interventions: Drug: Tacrolimus (Kidney transplant maintenance immunosuppression);   Drug: Kidney transplant maintenance immunosuppression
5 Recruiting Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Condition: Kidney Transplantation
Intervention: Procedure: Kidney transplantation
6 Recruiting Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
Condition: Function of Renal Transplant
Intervention: Other: Renal Transplant
7 Completed Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts
Condition: Renal Transplant Rejection
Interventions: Procedure: Kidney transplantation with MSCs infusion;   Procedure: kidney transplantation without MSC infusion
8 Completed Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease
Conditions: Type 1 Diabetes Mellitus;   End-stage Renal Disease
Intervention: Procedure: simultaneous islet-kidney transplantation
9 Recruiting Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Conditions: Multiple Myeloma;   End Stage Renal Disease
Interventions: Drug: Cyclophosphamide, anti-thymocyte globulin, cyclosporine;   Procedure: Kidney transplant;   Radiation: Thymic irradiation;   Procedure: Bone marrow transplant from a related donor
10 Completed Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Conditions: Kidney Transplantation;   Kidney Disease;   Kidney Failure
Interventions: Drug: Alemtuzumab;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Drug: Tacrolimus;   Procedure: Donor bone marrow stem cell infusion;   Procedure: Kidney transplant
11 Completed Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
Conditions: Renal Failure, Chronic;   Renal Transplantation
Interventions: Drug: intravenous immunoglobulins (IVIG);   Procedure: kidney transplantation
12 Completed Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
Condition: Renal Failure, Chronic
Interventions: Procedure: Kidney transplantation;   Drug: cyclosporine A;   Drug: tacrolimus;   Drug: azathioprine;   Drug: mycophenolate mofetil
13 Completed Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
Conditions: Kidney Failure, Chronic;   Multiple Myeloma
Intervention: Procedure: Combined bone marrow and kidney transplant
14 Unknown † Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Conditions: End-Stage Renal Disease;   Kidney Failure;   Kidney Transplantation
Interventions: Drug: Anti-thymocyte Globulin (rabbit) (rATG) (Thymoglobulin);   Drug: Divided-dose Thymoglobulin administration
15 Unknown † Cardiovascular Evaluation Before Renal Transplantation
Conditions: Chronic Kidney Disease;   Coronary Artery Disease
Intervention: Other: diagnostic procedure
16 Active, not recruiting Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
Condition: Kidney Transplantation
Intervention: Procedure: Kidney transplantation
17 Recruiting A Prospective, Open Label Study of CERtican in KIdney Transplantation
Condition: Kidney Transplant
Intervention: Drug: Everolimus
18 Recruiting Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
Conditions: Kidney Transplantation;   Rituximab;   Living Donors;   Immunology;   Virus
Interventions: Drug: Rituximab;   Procedure: living donor transplantation;   Procedure: deceased donor transplantation
19 Completed Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation
Condition: Kidney Transplantation
Intervention: Other: Observations
20 Completed Short Transverse Versus Conventional Hockey Stick Incision in Kidney Transplantation
Condition: Kidney Transplantation
Interventions: Procedure: Short Transverse Incision;   Procedure: Hockey Stick Incision

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services